Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Cisplatin
  • Hearing Loss
  • Neuroblastoma

abstract

  • Ototoxicity is a serious and pervasive problem in this patient population. Strategies to ameliorate ototoxicity without compromising on antitumor activity of treatments are urgently needed.

publication date

  • July 15, 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.22004

PubMed ID

  • 16779793

Additional Document Info

start page

  • 417

end page

  • 22

volume

  • 107

number

  • 2